SCHEMBL2337524

SCHEMBL2337524

CCCNCC(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11421855 0.98 ANPEP (0.41)
SCHEMBL3259539 0.87 ANPEP (0.46)
SCHEMBL6173378 0.86 TSHR (0.44)
SCHEMBL7705657 0.84 ALDH1A1 (0.50)
SCHEMBL24835071 0.82 ANPEP (0.49)
SCHEMBL6924948 0.82 ANPEP (0.49)
SCHEMBL9115910 0.82 ANPEP (0.49)
SCHEMBL3837850 0.82 ANPEP (0.49)
SCHEMBL24835020 0.82 ANPEP (0.49)
SCHEMBL3842331 0.82 ANPEP (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129581-A Solvent composition and method for producing sintered body 株式会社大赛璐 2025-06-10 CN disclosed
CN-115151360-B Dispersion medium for sintering metal particles and conductive paste 株式会社大赛璐 2025-01-07 CN disclosed
CN-118175983-A Hair treatment composition 莱雅公司 2024-06-11 CN disclosed
CN-113271917-B Hair care and conditioning compositions 莱雅公司 2023-07-07 CN disclosed
EP-4104865-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATES AbbVie Inc. (US) 2022-12-21 EP disclosed
CN-115151360-A Dispersion medium for sintering metal particles and conductive paste 株式会社大赛璐 2022-10-04 CN disclosed
EP-3468996-B1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC (US) 2022-05-04 EP disclosed
US-10251845-B2 Fatty acid cysteamine conjugates and their use as activators of autophagy CATABASIS PHARMACEUTICALS, INC. (US) 2019-04-09 US disclosed
WO-2017214335-A1 ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214282-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
US-7495110-B2 Benzimidazole derivatives and their use as GnRH antagonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-02-24 US disclosed
WO-2009022171-A1 PYRIDINYIIOXY PYRIDINES AS ALK5 INHIBITORS ASTRAZENECA AB (SE) 2009-02-19 WO disclosed
EP-1201644-A2 A process for the prepration of a dihydroxyamino compound Daicel Chemical Industries, Ltd. (JP) 2002-05-02 EP disclosed
EP-1102775-A1 NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2001-05-30 EP disclosed
WO-2000008031-A1 NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2000-02-17 WO disclosed
US-5874624-A REACTING EPOXY COMPOUND AND AN AMINO COMPOUND AT A SPECIFIED TEMPERATURE AND PRESSURE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-02-23 US disclosed
EP-0839802-A2 A process for the preparation of a dihydroxyamino compound DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1998-05-06 EP disclosed
US-5495005-A ANTICOAGULANTS, CARDIOVASCULAR DISORDERS NATIONAL SCIENCE COUNCIL (TW) 1996-02-27 US disclosed
EP-0005142-A1 Phenylpiperazine derivatives, process for their preparation, intermediates for this purpose and medicaments containing such phenylpiperazine derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-11-14 EP disclosed
US-4038418-A MOISTURIZING HENKEL & CIE G.M.B.H (DT) 1977-07-26 US disclosed